Trial intelligence / Profile preview

Relative bioavailability of topical diclofenac diethylamine with phonophoresis versus soft tissue mobilization

PACTR202608825248446Phase 3Completed

Start
Apr 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of diclofenac diethylammonium (2 arms), sponsored by None. Primary endpoints: Cmax, Tmax and 1 more. Started Apr 2026; status: completed.

02

Drugs

diclofenac diethylammonium

Beyond the preview

Go deeper on PACTR202608825248446.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202608825248446.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call